Allogene Therapeutics, Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Contribution Agreements (2 contracts)
- Investor Rights Agreements (1)
- Share Agreements (2)
- Shareholders Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (2)
- Description of Common Stock (Filed With SEC on February 28, 2023)
- First Amendment to the Share Purchase Agreement, dated May 11, 2022, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited (Filed With SEC on August 9, 2022)
- Share Purchase Agreement, dated December 14, 2020, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited (Filed With SEC on February 25, 2021)
- Shareholders' Agreement, dated December 14, 2020, by and among the Registrant, Overland Pharmaceuticals (CY) Inc. and Allogene Overland Biopharm (CY) Limited (Filed With SEC on February 25, 2021)
- Underwriting Agreement, dated June 1, 2020, by and among Goldman Sachs & Co. LLC, Jefferies LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 4, 2020)
- Description of Common Stock (Filed With SEC on February 27, 2020)
- Form of Underwriting Agreement (Filed With SEC on October 2, 2018)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on October 2, 2018)
- Asset Contribution Agreement, dated April 2, 2018, by and between the Registrant and Pfizer Inc (Filed With SEC on October 2, 2018)
- Allogene Therapeutics, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on October 2, 2018)
- Investors Rights Agreement, dated April 6, 2018, by and among the Registrant and certain of its securityholders, as amended September 5, 2018 (Filed With SEC on September 14, 2018)
- Asset Contribution Agreement, dated April 2, 2018, by and between the Registrant and Pfizer Inc (Filed With SEC on September 14, 2018)
